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Abstract The solution structure of the Eps15 homology (EH)
domain of a human POB1 (partner of RalBP1) has been
determined by uniform 13C/15N labeling and heteronuclear
multidimensional nuclear magnetic resonance spectroscopy. The
POB1 EH domain consists of two EF-hand structures, and the
second one binds a calcium ion. In the calcium-bound state, the
orientation of the fourth K-helix relative to the other helices of
the POB1 EH domain is slightly different from that of calbindin,
and much more different from those of calmodulin and troponin
C, on the basis of their atomic coordinates.
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1. Introduction
The POB1 (partner of RalBP1) protein was originally iden-
ti¢ed as a protein that interacts with the Ral-binding protein 1
(RalBP1), a putative e¡ector of a low-molecular-weight GTP-
binding protein, Ral [1]. POB1 also binds to Grb2, becomes
tyrosine-phosphorylated in response to epidermal growth fac-
tor (EGF), and makes a complex with the EGF receptor. The
function of POB1 is not well known, but POB1 is thought to
be an adapter protein that links a protein tyrosine kinase, a
Src homology 3 (SH3) domain-containing protein, and Ral.
POB1 consists of two proline-rich motifs, the coiled-coil re-
gion that interacts with RalBP1, and an Eps15 homology
(EH) domain in the central region.
The EH domain was ¢rst identi¢ed as an internal repeat in
Eps15, a substrate for the EGF receptor (EGFR) [2,3], and
has now been found in many eukaryotic proteins from yeast
to mammals [4]. Proteins with this domain are involved in
endocytosis [5^9], actin cytoskeleton organization [5,6], and
tyrosine kinase signaling pathways [1,10]. The EH domain
has been reported to interact with proteins containing the
Asn-Pro-Phe (NPF) motif, such as NUMB [11], RAB [11],
synaptojanin [12], yAP180A [13], and epsin [14]. The EH do-
main consists of about 100 amino acid residues, and has se-
quence homology with EF-hand calcium-binding domains
[2,3]. However, the binding of the EH domains of Eps15 to
other proteins does not seem to be a¡ected by the calcium
concentration in vitro [3]. The POB1 EH domain has a high
sequence homology with other EH domains. The POB1 EH
domain has a calcium-binding site, while other EH domains
have either one or none. In the present study, we determined
the solution structure of the POB1 EH domain using hetero-
nuclear multidimensional NMR spectroscopy. We also inves-
tigated calcium binding by the POB1 EH domain.
2. Materials and methods
2.1. Protein expression and puri¢cation
The POB1 EH domain (residues 126^227) was expressed as a glu-
tathione S-transferase (GST) fusion protein (Pharmacia Biotech Inc.).
The uniformly 15N- and 15N/13C-labeled proteins were obtained by
culture of Escherichia coli BL21 cells carrying this plasmid in M9
minimal medium supplemented with MgSO4 (3 mM), CaCl2
(300 WM), a trace element solution, a vitamin solution, ampicillin
(0.06 mg/ml), and 15NH4Cl (1 g/l) as the sole nitrogen source and/
or [13C6]D-glucose (3 g/l) as the sole carbon source. Harvested cells
were suspended in 50 mM Tris-HCl bu¡er (pH 7.5) containing
100 mM NaCl, 5 mM CaCl2, 2 mM DTT, 1 mM PMSF, and 0.1%
(v/v) Triton, and were disrupted by sonication. After centrifugation,
the supernatant was loaded onto a glutathione Sepharose 4B column
(Pharmacia Biotech Inc.) equilibrated with 50 mM Tris-HCl bu¡er
(pH 7.5) containing 100 mM NaCl, 5 mM CaCl2, 2 mM DTT, and
1 mM PMSF. The bound proteins were eluted with the same bu¡er
(pH 8.0) containing 15 mM glutathione (Sigma), and the fractions
containing the fusion protein were concentrated with a Centriprep-
10 unit (Amicon Inc.). The fusion protein was cleaved with thrombin
(Sigma) for 1 h at 25‡C, and then was applied to a DEAE Sephacel
column (Pharmacia Biotech Inc.) equilibrated with 50 mM Tris-HCl
bu¡er (pH 7.5) containing 5 mM CaCl2 and 2 mM DTT. The bound
proteins were eluted with an NaCl gradient (0^400 mM), and the
fractions containing the EH domain were concentrated with Centri-
prep-3 and Centricon-3 units (Amicon Inc.). The protein was further
puri¢ed by a FPLC Superdex 75 gel-¢ltration column (Pharmacia
Biotech Inc.) equilibrated with 50 mM Tris-HCl bu¡er (pH 7.5) con-
taining 150 mM NaCl, 5 mM CaCl2, and 2 mM DTT. The fractions
containing the EH domain were concentrated with a Centricon-3 unit
(Amicon Inc.). The purity of the EH domain was veri¢ed by SDS-
PAGE and mass spectrometry. The concentrations of the EH domain
for the NMR analyses were 1.0 mM for the 15N-labeled and 2.0 mM
for the 15N/13C-labeled samples, in 90% H2O/10% 2H2O bu¡er con-
taining 20 mM 2H6 Tris-HCl (pH 7.5), 50 mM KCl, 5 mM 2H10 DTT,
0.01% sodium azide, and 5 mM CaCl2 for the 15N-labeled and
10.0 mM CaCl2 for the 15N/13C-labeled samples.
2.2. NMR spectroscopy
All NMR experiments were performed at 303 K on a Bruker
DRX600 spectrometer equipped with a triple resonance, pulse-¢eld
gradient probe. All spectra that detected NH magnetization were ob-
tained using the water £ip-back method [15]. The 2D 1H-15N HSQC
[16], 3D 15N-edited TOCSY-HSQC (37 ms mixing time) [17], 15N-
edited NOESY-HSQC (80 ms mixing time) [18], and HNHB [19]
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spectra were recorded for the 15N-labeled sample. The 3D HNCA
[20], HN(CO)CA [21], HNCO [20], HCACO [20], CBCANH [22],
CBCA(CO)NH [23], HBHA(CO)NH [24], C(CO)NH [25], HCCH-
TOCSY (20 ms mixing time) [26], HCCH-COSY [27], 13C-edited
NOESY-HSQC (100 ms mixing time) [28], 4D 13C/15N-edited NOESY
(100 ms mixing time) [29], and 13C/13C-edited NOESY (100 ms mixing
time) [30] spectra were also recorded for the 15N/13C-labeled sample.
All spectra were processed on an Indigo2 IMPACT workstation (Sil-
icon Graphics), using the NMRPipe system [31]. Analyses of the
processed data were performed with the NMRView software package
[32].
2.3. EDTA titration of the POB1 EH domain
The titration experiments of the POB1 EH domain with EDTA,
using NMR analysis, were performed with 0.6 mM of the 15N-labeled
POB1 EH domain in 20 mM 2H6 Tris-HCl bu¡er (pH 7.5) containing
50 mM KCl, 5 mM 2H10 DTT, 0.01% sodium azide, and 3 mM
CaCl2. The 2D 1H-15N HSQC spectra were acquired at EDTA con-
centrations of 0, 1.0, 2.0, 2.5, 3.0, 3.6, and 6.0 mM.
2.4. Distance restraints
Interproton distance restraints were obtained from the 3D 15N-
edited NOESY-HSQC and 13C-edited NOESY-HSQC spectra. The
4D 15N/13C-edited NOESY and 13C/13C-edited NOESY spectra were
used only to identify the overlapped crosspeaks observed in the 3D
spectra, and were not used for the calculation. The assigned nuclear
Overhauser enhancements (NOEs) were classi¢ed into upper bound
distance restraints of 2.9, 3.5, 4.5, and 5.5 Aî for the NOEs from the
15N-edited NOESY-HSQC spectrum, and 2.7, 3.3, 4.5, and 5.5 Aî for
the NOEs from the 13C-edited NOESY-HSQC spectrum. The lower
bounds for the interproton distance restraints were set to 1.8 Aî . Dis-
tances involving methyl groups, aromatic ring protons, and non-
stereospeci¢cally assigned methylene protons were represented as
(4 r36)31=6 sums [33]. The backbone hydrogen bond restraints were
treated as previously described [34]. First, the secondary structure
elements of the POB1 EH domain were determined by the NOE con-
nectivities such as NH(i)-NH(i+1), HK(i)-NH(i+1), HK(i)-NH(i+2),
HK(i)-NH(i+3), HK(i)-NH(i+4), and HK(i)-HL(i+3) [35]. Then, the hy-
drogen bond restraints were given for the residue pairs that are in-
volved in the secondary structure elements, and moreover exhibit no
cross peak between NH and H2O in the 3D 15N-edited NOESY-
HSQC spectrum measured by the water £ip-back method. The upper
and lower limits of the constraints for N-O were 3.5 and 2.5 Aî ,
respectively, and those for NH-O were 2.5 and 1.5 Aî , respectively.
In addition, six distance restraints (2.0^2.8 Aî ) between the single
calcium ion and the interacting oxygen atoms were included, based
on the structures of other EF-hand proteins [36^41].
2.5. Dihedral angle restraints and stereospeci¢c assignments
The P and i dihedral angle restraints were given for the residues
that are involved in the secondary structure elements determined by
the NOE connectivities, and moreover have consistent chemical shift
indices [42], as previously described [43]. In the K-helical regions, the P
and i angles were restrained to 365‡ and to 340‡ with allowed
ranges of þ 30‡, respectively. In the L-sheet region, the P and i angles
were restrained to 3120‡ and to 130‡ with allowed ranges of þ 30‡,
respectively. The M1 angle restraints were obtained from the 3D 15N-
edited HNHB, 15N-edited TOCSY-HSQC, and 15N-edited NOESY-
HSQC spectra. The M1 angles were restrained to 360‡ with allowed
ranges of þ 30‡.
2.6. Structure calculations
Structures were calculated using the simulated annealing protocol
[44] with X-PLOR 3.1 [45]. The ¢nal structure calculation was based
on a total of 1527 restraints: 1444 interproton distance restraints (970
interresidue distance restraints), 22 distance restraints for 11 backbone
hydrogen bonds, 61 dihedral angle restraints of 30 P, 28 i, and three
M1, and six distance restraints between the single calcium ion and the
interacting oxygen atoms. All structure calculations were performed
on an Indigo2 IMPACT workstation (Silicon Graphics).
3. Results and discussion
3.1. Calcium binding of the POB1 EH domain
As the EH domains have sequence homology with the EF-
hand calcium-binding domains, we studied the calcium bind-
ing of the POB1 EH domain using EDTA titration. Fig. 1
shows the 1H-15N HSQC spectra of the POB1 EH domain
with and without EDTA. Most of the peaks disappeared after
the addition of 6 mM EDTA, indicating that the POB1 EH
domain is tightly bound with Ca2 and that the removal of
Ca2 results in denaturation or aggregation. The addition of
calcium to this EDTA-treated solution failed to restore the
initial spectrum (data not shown). Therefore, the denaturation
(or aggregation) upon calcium removal is irreversible. Fur-
thermore, gel-¢ltration and light-scattering experiments
showed that the POB1 EH domain is in an aggregation state
in the absence of Ca2, but is in a monomeric state in the
presence of Ca2 (data not shown). The second EF-hand cal-
cium-binding motif of the POB1 EH domain has the con-
served residues required for calcium binding, but the ¢rst
motif does not, indicating that the POB1 EH domain binds
only one calcium ion.
The EF-hand domains of calbindin and calmodulin have
two calcium-binding sites per EF-hand domain [37,41], and
their calcium-free states are stable enough for NMR analyses
[46^49]. On the other hand, the POB1 EH domain has one
calcium-binding site, and the dissociation of the calcium ion
seems to make it very unstable. These data show that the
calcium ion of the POB1 EH domain is necessary for the
structure, and that the functions of the POB1 EH domain,
which are still unknown, may not be regulated by the calcium
concentration.
3.2. Resonance assignments
Sequence-speci¢c assignments of the backbone, CL, and HL
resonances were obtained by analysis of the 3D HNCA,
HN(CO)CA, HNCO, HCACO, CBCANH, CBCA(CO)NH,
HBHA(CO)NH, 15N-edited TOCSY, and 15N-edited NOESY
spectra. Of the 99 expected backbone amide resonances, 90
were observed in the 1H-15N HSQC spectrum of the POB1
EH domain. The missing peaks are those of the N-terminal six
residues (Gly-1^Asn-6), the N-terminal residue of the second
K-helix (Ser-42), the residue located in the loop between the
second and third K-helices (Ile-55), and the residue located in
the C-terminal extended region (Glu-96). These missing peaks
are those of the residues exposed to the solvent as described
below, indicating that the lack of these peaks is due to amide
exchange with the solvent. The assignments of the aliphatic
1H and 13C resonances were mainly obtained from the 3D
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Fig. 1. 1H-15N HSQC NMR spectra of 0.6 mM of the uniformly
15N-labeled POB1 EH domain with 3.0 mM CaCl2, in the presence
of (a) 0 mM EDTA and (b) 6.0 mM EDTA.
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15N-edited TOCSY, HCCH-TOCSY, HCCH-COSY, and
C(CO)NH spectra, whereas those of the aromatic ring reso-
nances were obtained from the 3D HCCH-COSY and 13C-
edited NOESY spectra.
3.3. Secondary structure determination
The secondary structure of the POB1 EH domain was de-
termined on the basis of the 3D 15N-edited and 13C-edited
NOESY spectra. The sequential and medium-range NOEs,
the backbone hydrogen bonds, and the 13CK chemical shift
indices are summarized in Fig. 2. We identi¢ed four K-helices
(K1^K4) and one short L-sheet (L1 and L2) in the secondary
structure of the POB1 EH domain (Fig. 2).
3.4. Tertiary structure determination
The three-dimensional structure of the POB1 EH domain
was determined from a total of 1527 restraints. The 18 ¢nal
simulated-annealing structures satisfy the distance restraints,
and have no violations greater than 0.3 Aî and no dihedral
angle violations greater than 3‡. These structures were aligned
by superimposing the backbone atoms (N, CK, and CP) of the
secondary structure elements, and are shown in Fig. 3a. The
average root-mean-square (rms) deviation was 0.76 ( þ 0.49) Aî
for the backbone atoms of the secondary structure elements
(Table 1).
The sequence distribution of the intra- and interresidue
NOE distance restraints is shown in Fig. 4. A number of
interresidue NOEs were acquired for the secondary structure
elements, although only a few interresidue NOEs were ob-
served for the three loop regions (residues 32^37, 50^56, and
66^71) and for the N- and C-terminal regions (residues 1^17
and 91^110).
Fig. 3b shows a schematic ribbon diagram of the solution
structure of the POB1 EH domain. This structure consists of a
pair of helix-loop-helix (HLH) motifs, which make hydropho-
bic interactions, and their two loops constitute a short anti-
parallel L-sheet. The interhelical angle within the ¢rst HLH
motif is much smaller than that within the second HLH motif.
The three C-terminal K-helices (K2^K4) interact tightly with
each other, and make a bundle structure. The second and
fourth helices (K2 and K4) are nearly parallel, and the third
helix (K3) is slightly tilted in comparison. On the other hand,
the N-terminal K-helix (K1) is bound mainly to K4, with an
angle of about 113‡ relative to K2 and K4. The calcium ion is
located in the loop region of the second EF-hand motif.
The C-terminal region of the POB1 EH domain contains
many proline residues, which are well conserved among EH
FEBS 21388 13-1-99
Table 1
Structural statistics of the 18 NMR structures
X-PLOR energies (kcal/mol)
Etotal 185 þ 10
Ebond 6.0 þ 0.8
Eangle 138 þ 6
Eimproper 19 þ 2
Evdw 9.5 þ 3.5
Enoe 13 þ 4
Ecdih 0.04 þ 0.17
Elÿj 3296 þ 64
rms deviations from idealized geometry
Bonds (Aî ) 0.002 þ 0.000
Angles (‡) 0.54 þ 0.011
Impropers (‡) 0.37 þ 0.015
rms deviations from distance restraints
All (Aî ) 0.014 þ 0.002
rms deviations from experimental dihedral angle restraints
All (‡) 0.08 þ 0.15
rms deviations about mean coordinate positions (Aî )
Secondary structure elements
backbone (N, CK, and CP) 0.76 þ 0.49
all non-H 1.19 þ 0.46
Fig. 2. Diagram of the sequential and medium-range NOE connectivities, the backbone hydrogen bonds, and the 13CK chemical shift indices.
The height of the bars re£ects the strength of the NOE correlation, as strong, medium, weak, or very weak. The NOE connectivities that could
not be established unambiguously because of overlaps are marked by open boxes (dNN and dKN) or dashed lines (dKN and dKL). The residues
that lacked a cross peak between the HN and H2O resonances in the 3D 1H-15N NOESY-HSQC spectrum are indicated by 8.
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domains. Some NOEs were observed between this proline-rich
region and the second HLH motif, but the low number of
restraints did not allow the structure of this proline-rich re-
gion to be determined well.
3.5. Comparison of the structure of the POB1 EH domain with
those of other EF-hand domains
We compared the structure of the POB1 EH domain with
those of other calcium-bound EF-hand proteins [37^
39,41,50,51]. The secondary structure elements (four K-helices
and two L-strands) and their topology within the POB1 EH
domain are basically similar to those of other EF-hand do-
mains. In more detail, the three-dimensional structure of the
calcium-bound POB1 EH domain is similar to the closed con-
formation of calcium-bound calbindin [41], but is clearly dif-
ferent from the open conformations of calcium-bound cal-
modulin and troponin C [37^39]. Compared to the structure
of calcium-bound calbindin, however, the fourth helix (K4) of
the calcium-bound POB1 EH domain is more tightly packed
with the third helix (K3). This interhelical angle (about 141‡)
seems to be similar to those of the solution structures of
calcyclin and S100B [50,51], although the coordinates of these
two proteins are not available. The sequences of the EH do-
mains, especially the residues required for the hydrophobic
core, are well conserved, indicating that these structural fea-
tures are also conserved among the EH domains [1,3,4]. Fur-
thermore, the EH domains recognize the Asn-Pro-Phe (NPF)
motif [11^14], which is a di¡erent type of ligand recognition
from those used by other EF-hand proteins [52^54]. There-
fore, the EH domains constitute a distinct group within the
EF-hand protein family.
During the preparation of this article, the structure and the
peptide-binding site of the second EH domain (EH2) of Eps15
were reported [55]. The structure of the Eps15 EH2 domain
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Fig. 4. The distribution of the NOE contacts in the POB1 EH domain as a function of the sequence position. Inter- and intraresidue NOEs
are shown as open and ¢lled boxes, respectively.
Fig. 3. a: The 18 backbone structures of the POB1 EH domain (residues 10^100), which were superimposed for the minimal rms deviation of
the backbone atoms (N, CK, and CP) of the secondary structure elements. This ¢gure was generated using MIDASPlus [56]. b: Ribbon repre-
sentation of the solution structure of the POB1 EH domain (residues 10^100). The amino- and carboxy-termini are indicated. The drawing was
made with MOLSCRIPT [57].
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appears to be signi¢cantly similar to the POB1 EH domain,
although the C-terminal proline-rich region of the Eps15 EH2
domain is tightly packed with the second EF-hand motif. This
domain also binds one calcium ion in its second EF-hand
motif. However, its calcium-free state was stable enough to
be observed by NMR, whereas the calcium-free state of the
POB1 EH domain was very unstable, suggesting that the cal-
cium ion of the POB1 EH domain has a more critical role in
structural stability than that of the Eps15 EH2 domain. The
peptide-binding site of the Eps15 EH2 domain is located in
the hydrophobic pocket between the second and third helices,
which is di¡erent from the ligand-binding sites of other EF-
hand proteins. The residues constituting this hydrophobic
pocket are well conserved among the EH domains, including
the POB1 EH domain, indicating that this binding mode is
conserved.
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